{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:10:31Z","timestamp":1789848631751,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Orthopaedic Science"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00776-009-1355-6","type":"journal-article","created":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T23:25:25Z","timestamp":1254439525000},"page":"623-630","source":"Crossref","is-referenced-by-count":12,"title":["Increased p21 expression in chondrocytes of achondroplasic children independently from the presence of the G380R FGFR3 mutation"],"prefix":"10.1016","volume":"14","author":[{"given":"Antonina","family":"Parafioriti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Del","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Barisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Armiraglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Peretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Albisetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s00776-009-1355-6_bb0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1399-0004.1989.tb02912.x","article-title":"Birth prevalence rates of skeletal dysplasias","volume":"35","author":"Stoll","year":"1989","journal-title":"Clin Genet"},{"key":"10.1007\/s00776-009-1355-6_bb0010","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/302000","article-title":"Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome","volume":"63","author":"Wilkin","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s00776-009-1355-6_bb0015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/302275","article-title":"A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene","volume":"64","author":"Tavormina","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s00776-009-1355-6_bb0020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1023\/A:1020914026829","article-title":"Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism","volume":"3","author":"Horton","year":"2002","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1007\/s00776-009-1355-6_bb0025","series-title":"Bone dysplasias: an atlas of genetic disorders of skeletal development","author":"Spranger","year":"2002"},{"key":"10.1007\/s00776-009-1355-6_bb0030","first-page":"368","article-title":"Achondroplasia is defined by recurrent G380R mutations of FGFR3","volume":"56","author":"Bellus","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s00776-009-1355-6_bb0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat Genet"},{"key":"10.1007\/s00776-009-1355-6_bb0040","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1101\/gad.990702","article-title":"FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease","volume":"16","author":"Ornitz","year":"2002","journal-title":"Genes Dev"},{"key":"10.1007\/s00776-009-1355-6_bb0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signalling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"key":"10.1007\/s00776-009-1355-6_bb0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/386288a0","article-title":"Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism","volume":"386","author":"Su","year":"1997","journal-title":"Nature"},{"key":"10.1007\/s00776-009-1355-6_bb0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bone.2003.09.002","article-title":"Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias","volume":"34","author":"Legeai-Mallet","year":"2004","journal-title":"Bone"},{"key":"10.1007\/s00776-009-1355-6_bb0060","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1101\/gad.13.11.1361","article-title":"FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway","volume":"13","author":"Sahni","year":"1999","journal-title":"Genes Dev"},{"key":"10.1007\/s00776-009-1355-6_bb0065","doi-asserted-by":"crossref","first-page":"15962","DOI":"10.1074\/jbc.M102777200","article-title":"Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation","volume":"277","author":"Kong","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1007\/s00776-009-1355-6_bb0070","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.1074\/jbc.M108653200","article-title":"Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF- 10","volume":"277","author":"Shimoaka","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1007\/s00776-009-1355-6_bb0075","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ng0496-390","article-title":"Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3","volume":"12","author":"Colvin","year":"1996","journal-title":"Nat Genet"},{"key":"10.1007\/s00776-009-1355-6_bb0080","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"},{"key":"10.1007\/s00776-009-1355-6_bb0085","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1172\/JCI6690","article-title":"Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis","volume":"104","author":"Chen","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1007\/s00776-009-1355-6_bb0090","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1073\/pnas.96.8.4455","article-title":"A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3","volume":"96","author":"Wang","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s00776-009-1355-6_bb0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/8.1.35","article-title":"A Lys-644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors","volume":"8","author":"Li","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s00776-009-1355-6_bb0100","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gad.1179104","article-title":"Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the FGFR3-deficient mouse phenotype","volume":"18","author":"Murakami","year":"2004","journal-title":"Genes Dev"},{"key":"10.1007\/s00776-009-1355-6_bb0105","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/(SICI)1098-1004(1997)10:6<496::AID-HUMU13>3.0.CO;2-V","article-title":"An improved methodology for the detection of the common mutation in the FGFR3 gene responsible for achondroplasia","volume":"10","author":"Lanning","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1007\/s00776-009-1355-6_bb0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s004390050493","article-title":"Human fibroblast growth factor receptor 3 gene (FGFR3): genomic sequence and primer set information for gene analysis","volume":"100","author":"W\u00fcchner","year":"1997","journal-title":"Hum Genet"},{"key":"10.1007\/s00776-009-1355-6_bb0115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","article-title":"Achondroplasia","volume":"370","author":"Horton","year":"2007","journal-title":"Lancet"},{"key":"10.1007\/s00776-009-1355-6_bb0120","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/sj.ejhg.5201700","article-title":"Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia","volume":"14","author":"Heuertz","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1007\/s00776-009-1355-6_bb0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.ejhg.5201931","article-title":"Novel FGFR3 mutations in exon 7 and implications for expanded screening of achondroplasia and hypo-chondroplasia: a response to Heuertz et al","volume":"16","author":"Friez","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1007\/s00776-009-1355-6_bb0130","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1399-0004.2008.01123.x","article-title":"Clinical and molecular diagnosis of the skeletal dysplasias associated with mutations in the gene encoding fibroblast growth factor receptor 3 (FGFR3) in Portugal","volume":"75","author":"Almeida","year":"2009","journal-title":"Clin Genet"},{"key":"10.1007\/s00776-009-1355-6_bb0135","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/hmg\/ddi161","article-title":"Sustained ERK1\/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells","volume":"14","author":"Nowroozi","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s00776-009-1355-6_bb0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4161\/cc.3.3.720","article-title":"Cell cycle control: a complex issue","volume":"3","author":"Olashaw","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1007\/s00776-009-1355-6_bb0145","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1128\/MCB.24.3.1188-1199.2004","article-title":"BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1\/WAF1\/SDI","volume":"24","author":"Kang","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1007\/s00776-009-1355-6_bb0150","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.1038\/sj.onc.1206019","article-title":"Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1)","volume":"21","author":"Sugimoto","year":"2002","journal-title":"Oncogene"}],"container-title":["Journal of Orthopaedic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265815320571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265815320571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00776-009-1355-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T20:16:57Z","timestamp":1558556217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0949265815320571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0949265815320571"],"URL":"https:\/\/doi.org\/10.1007\/s00776-009-1355-6","relation":{},"ISSN":["0949-2658"],"issn-type":[{"value":"0949-2658","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}